ERBB2 and cancer: The phenotypic plasticity of tumor cells, which is controlled by both intrinsic and microenvironmental cues, can result in the appearance of mesenchymal-like or cancer stem cell-like cells with reduced sensitivity to anti-HER2 drugs [213,214].